A new technique from Stanford, Nvidia, and Together AI lets models learn during inference rather than relying on static ...

Canopy Network has announced it is launching Canopy Templates, a new blockchain building tool designed to aid in AI-assisted ...

This voice experience is generated by AI. Learn more. This voice experience is generated by AI. Learn more. Leaders don’t ...

Imre Szenttornyay, CEO of Cielo IT LLC, empowers business owners to scale their operations profitably with AI-powered SmartSigns technology. When you manage a network of retail or franchise locations, ...

Recursion Pharmaceuticals (RXRX) added ~11% in the morning trading on Wednesday after J.P. Morgan upgraded the AI-driven biotech to Overweight from Neutral, citing a blockbuster sales potential for ...

This year artificial intelligence stopped being all about the future and roared into the present. Time announced exclusively on TODAY Dec. 11 that it has recognized AI’s seismic impact by naming the ...

After twelve years at the helm of AI-drug developer Recursion, Chris Gibson will hand the CEO baton to Najat Khan, PhD, the company’s chief R&D officer and chief commercial officer, effective January ...

Abstract: Time-series forecasting demands efficient modeling of long-range dependencies while maintaining computational practicality. Current methods, particularly deep learning approaches, often ...

Andrew Joseph covers health, medicine, and the biopharma industry in Europe. You can reach Andrew on Signal at drewqjoseph.71. LONDON — In the year-plus since Najat Khan joined the AI-focused drug ...

Welcome to this week's Chutes & Ladders, our roundup of significant leadership hirings, firings and retirings across the industry. Please send the good word—or the bad—from your shop to Darren ...

Management reaffirmed guidance for 2025 on an expense base of less than $450 million, "excluding all of the partnership inflows." For 2026, guidance was also reaffirmed at less than $390 million.